ASXL1 and myelodysplastic syndrome: Compared to patients without ASXL1 deletion, patients with ASXL1 deletion tend to be associated with worse OS in the MDS‐LB subgroup (median OS, not reached, p = 0.10; Figure 5H), but not in the cohort (median OS, not reached, p = 0.99; Figure 5G).